Related Experiment Video
Updated: Jun 17, 2026

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
Cyclin-dependent kinase-9 is a component of the p300/GATA4 complex required for phenylephrine-induced hypertrophy in
Yoichi Sunagawa1, Tatsuya Morimoto1, Tomohide Takaya2
1Division of Translational Research, 1-1 Mukaihata-cho, Fukakusa, Fushimi-ku, Kyoto 612-8555.
Insights
Cyclin-dependent kinase-9 (Cdk9) interacts with GATA4 and p300, regulating cardiomyocyte hypertrophy. Cdk9 kinase activity is essential for GATA4 acetylation and p300 phosphorylation, crucial for heart function.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Epigenetics
Background:
- GATA4, a transcription factor, interacts with p300, a histone acetyltransferase, and is vital for cardiomyocyte hypertrophy.
- Disruption of the GATA4-p300 complex leads to heart failure.
- Understanding the regulation of this complex is crucial for cardiac health.
Purpose of the Study:
- To identify novel binding partners of GATA4.
- To elucidate the role of new partners in the GATA4-p300 complex.
- To investigate the functional significance of these interactions in cardiomyocyte hypertrophy.
Main Methods:
- Tandem affinity purification
- Mass spectrometry
- Co-immunoprecipitation
- In vivo studies of cardiomyocyte hypertrophy
Main Results:
- Cyclin-dependent kinase-9 (Cdk9) was identified as a novel GATA4-binding partner.
- Cdk9 forms a complex with GATA4, p300, and cyclin T1.
- Cdk9 kinase activity is required for GATA4 acetylation, p300 phosphorylation, and cardiomyocyte hypertrophy.
Conclusions:
- Cdk9 is a key component of the GATA4-p300 transcriptional complex.
- Cdk9 kinase activity is essential for the GATA4-p300 pathway in cardiomyocyte hypertrophy.
- Cdk9 represents a potential therapeutic target for heart failure.
Abstract:
A zinc finger protein GATA4 is one of the hypertrophy-responsive transcription factors and forms a complex with an intrinsic histone acetyltransferase, p300. Disruption of this complex results in the inhibition of cardiomyocyte hypertrophy and heart failure in vivo. By tandem affinity purification and mass spectrometric analyses, we identified cyclin-dependent kinase-9 (Cdk9) as a novel GATA4-binding partner. Cdk9 also formed a complex with p300 as well as GATA4 and cyclin T1. We showed that p300 was required for the interaction of GATA4 with Cdk9 and for the kinase activity of Cdk9. Conversely, Cdk9 kinase activity was required for the p300-induced transcriptional activities, DNA binding, and acetylation of GATA4. Furthermore, the kinase activity of Cdk9 was required for the phosphorylation of p300 as well as for cardiomyocyte hypertrophy. These findings demonstrate that Cdk9 forms a functional complex with the p300/GATA4 and is required for p300/GATA4- transcriptional pathway during cardiomyocyte hypertrophy.
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
GPCRs Regulate Adenylyl Cylase Activity
Two...
Positive Regulator Molecules
Positive Regulator Molecules
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
G-Protein Gated Ion Channels
Sensory organs,...
